Blue Ridge Cancer Care

What Blue Ridge Cancer Care does

Blue Ridge Cancer Care (BRCC) is a privately-owned, community-based multidisciplinary oncology practice founded in 1975 and headquartered in Roanoke, Virginia, serving patients across Southwest Virginia and adjacent parts of West Virginia. The practice delivers comprehensive cancer and hematology care through 18 physicians and 22+ advanced practice providers supported by 101–250 total employees across 11 physical locations, with telehealth extending reach into rural catchment areas. Core clinical services span medical oncology, hematology, and radiation oncology, with treatment modalities including chemotherapy, radiation therapy, hormone therapy, and targeted therapy, complemented by on-site laboratory, genetic testing, survivorship programs, and patient support services.

BRCC operates a dedicated Research Institute staffed by 15 clinical-research professionals and runs Phase I–IV oncology trials through US Oncology Research, an affiliation that has contributed to approximately one-third of all FDA-approved cancer therapies. The practice's technology footprint consists of standard clinical and patient-engagement tools — a NavigatingCare-based patient portal, telehealth for remote consultations, and infusion/radiation delivery systems — with no disclosed proprietary software or AI/ML capabilities. Care delivery is credentialed under the ASCO Patient-Centered Cancer Care Certification (2022) and participates in the CMS Oncology Care Model (since 2016), linking reimbursement to episode-based quality and performance metrics.

Revenue is generated through fee-for-service insurance reimbursement, Medicare/Medicaid, and value-based payments under the CMS Oncology Care Model, with patient acquisition driven primarily by referral relationships with primary care physicians and specialists rather than direct-to-consumer marketing. The practice is affiliated with The US Oncology Network, an organization of 1,200+ independent physicians supported by McKesson Corporation, which functions as the practice's strategic operating parent and provides shared clinical-trial infrastructure, procurement, and operational resources.

Name

Blue Ridge Cancer Care

Legal name

Blue Ridge Cancer Care

Website

https://blueridgecancercare.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

101–250 employees

Short description

Blue Ridge Cancer Care is a privately-owned community oncology practice founded in 1975, delivering medical, radiation, and hematology oncology plus Phase I–IV clinical trials across 11 locations in Southwest Virginia and West Virginia as a member of The US Oncology Network.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Other Outpatient Care Centers (62149), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Thoracic (Lung) Oncology (HLAKAFAL), Gynecologic Oncology (HLAKAFAF), Head & Neck Surgery (ENT Oncology) (HLAKAMAF), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology medical services
• Cancer treatment
• Radiation therapy
• Hematology care
• Clinical trials research

Headquarters

HQ city

Roanoke

HQ country

United States

HQ region

North America

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Oncology and Hematology Medical Services: Healthcare services provided to cancer and blood disorder patients including medical oncology, radiation oncology, hematology, chemotherapy, radiation therapy, hormone therapy, targeted therapy, genetic testing, laboratory services, and clinical trials. Revenue is generated through insurance reimbursement, Medicare/Medicaid, and value-based care arrangements under the CMS Oncology Care Model.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Blue Ridge Cancer Care is a privately-owned multidisciplinary oncology practice delivering integrated care for cancer and blood disorders. Services span medical oncology, hematology, radiation oncology, chemotherapy, radiation therapy, hormone therapy, targeted therapy, genetic testing, laboratory services, and Phase I-IV clinical trials across 11 locations in Southwest Virginia and West Virginia.

Product overview

Blue Ridge Cancer Care (BRCC) is a privately-owned multidisciplinary oncology practice providing comprehensive integrated cancer care across 12 locations in Southwest Virginia. The practice operates as a platform of interconnected services centered around three core physician specialties: Medical Oncology, Hematology, and Radiation Oncology. These specialties are supported by four main treatment modalities including Chemotherapy, Radiation Therapy, Hormone Therapy, and Targeted Therapy. BRCC's service ecosystem includes a Research Institute offering Phase I-IV clinical trials, Genetic Testing and Laboratory diagnostic services, Telehealth remote consultations, a Patient Portal for digital engagement, and Survivorship and Support Services programs. The practice is affiliated with The US Oncology Network and participates in US Oncology Research, which has contributed to approximately one-third of all FDA-approved cancer therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Medical oncology services including cancer diagnosis, treatment planning, and administration of chemotherapy and other systemic drug therapies for cancer patients.
• Hematology Specialized care for blood disorders and blood cancers including leukemia, lymphoma, multiple myeloma, and other hematological conditions.
• Radiation Oncology Radiation therapy services using advanced technologies to treat cancer through targeted radiation delivery, including stereotactic radiation.
• Chemotherapy Systemic cancer treatment using chemical substances to kill or inhibit cancer cells, administered in outpatient settings.
• Radiation Therapy Targeted radiation treatment for cancer using advanced technologies to precisely deliver radiation to tumor sites.
• Hormone Therapy Cancer treatment that uses hormones to block or alter hormone production to stop or slow cancer growth, typically for hormone-receptor-positive cancers.
• Targeted Therapy

Quantifiable outcome

• Nearly 1,200 patients enrolled in clinical trials over five years
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• Centers for Medicare & Medicaid Services (CMS)coreOthers · 1 January 2016Selected as one of nearly 200 physician group practices to participate in the Oncology Care Model, a care delivery model supporting and encouraging higher quality, coordinated cancer care with episode and performance-based payments.
• The US Oncology NetworkcoreStrategic or Co-development PartnerBlue Ridge Cancer Care is a practice in The US Oncology Network, uniting with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients close to home. The Network provides shared expertise and resources dedicated to advancing local cancer care and delivering better patient outcomes.
• McKesson CorporationcoreStrategic or Co-development PartnerMcKesson Corporation supports The US Oncology Network with coordinated resources and infrastructure, allowing doctors to focus on patient health while McKesson focuses on practice health. This partnership provides operational support and resources for network practices.
• US Oncology ResearchcoreStrategic or Co-development PartnerBlue Ridge Cancer Care participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date.
• LewisGale Regional Health SystemmajorStrategic or Co-development PartnerCollaboration between Blue Ridge Cancer Care and LewisGale Regional Health System resulted in a 13,000-square-foot cancer specialty center in Blacksburg, providing radiation and comprehensive cancer services to the New River Valley.
• Stand Up To CancerminorGTM or Marketing PartnerBRCC physicians participate in Roll Over Cancer fundraising events supporting Stand Up To Cancer, a charitable program of the Entertainment Industry Foundation that raises funds for translational cancer research.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• The US Oncology Network: BRCC's parent affiliate network of 1,200+ independent community oncology physicians. Directly comparable as it operates the same community-based, value-based oncology model with shared clinical trials, EHR (Navigating Care), and McKesson support.
• OneOncology: Network platform of community oncology practices competing head-to-head with US Oncology Network. Similar model: physician-led practices pooling back-office, clinical research, and value-based contracts. Directly comparable in segment and value proposition.
• Tennessee Oncology: Large community-based medical and radiation oncology practice (also a US Oncology Network affiliate) operating multi-specialty cancer centers with clinical trials, OCM participation, and similar regional multi-location model. Direct comparable on business model and service mix.
• Astera Cancer Care: New Jersey-based community oncology practice (US Oncology Network affiliate) delivering multi-specialty cancer care with clinical trials. Closely comparable mid-sized community oncology peer inside the same network.
• Sarah Cannon Research Institute: HCA-affiliated oncology research network running community-based Phase I trials and the Sarah Cannon network of cancer centers. Direct competitor to US Oncology Research for pharma-sponsored trial placement and a structural competitor to BRCC's research arm.
• GenesisCare: Global oncology and urology provider offering radiation oncology, medical oncology, and clinical trials across community settings. Comparable as a multi-modality community oncology platform with a clinical research arm, though operating at much larger scale.
• Virginia Oncology Associates: Hampton Roads-based community medical oncology and hematology practice offering chemotherapy, infusion, imaging, lab, and clinical trials. Direct comparable regional peer with overlapping service mix and customer segment (Virginia cancer patients).

Regional players

• Carilion Clinic Cancer Center: Roanoke-based academic-affiliated health system cancer program where BRCC's President Dr. David Buck also serves as medical director. Competes for Southwest Virginia oncology referrals and partners on research, making it a relevant regional peer despite different ownership model.

Emerging players

• American Oncology Network (AON): Network of community oncology practices offering medical oncology, infusion, radiation, and clinical trials with shared services. Comparable emerging peer consolidating independent oncology practices against larger networks.

Broad incumbents

• Vanderbilt-Ingram Cancer Center: NCI-designated academic cancer center in Nashville running high-acuity oncology, Phase I trials, and a regional referral base. Comparable as the broader incumbent whose quaternary offerings BRCC relies on for trial referral pathways and competes with for complex cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/blueridgecancer

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blue Ridge Cancer Care